26 May, 2023 Results from HELIOS-A RTE Period Presented during Annual Meeting of the ASNP
Nine month results from the randomized treatment extension (RTE) period of the HELIOS-A study of vutrisiran in patients with the polyneuropathy of hereditary ATTR amyloidosis were presented at the Italian Association for the Study of the Peripheral Nervous System.